Oral Cavity Squamous Cell Carcinoma · Fase 2 · NCT07121595
Biospecimen Collection, Carboplatin, Cisplatin, Computed Tomography
University of Michigan Rogel Cancer Center · Abrir el resumen
Locally Recurrent Oral Cavity Squamous Cell Carcinoma · Fase 2 · NCT06448026
Cemiplimab, Cetuximab
M.D. Anderson Cancer Center · Abrir el resumen
HPV-Related Oropharynx Squamous Cell Carcinoma · Fase 2 · NCT06702033
Radiation therapy, Cisplatin, Surgery
Washington University School of Medicine · Abrir el resumen
Oropharynx Cancer · Fase 2 · NCT05388773
therapeutic conventional surgery, laboratory biomarker analysis, quality-of-life assessment, intensity-modulated radiation therapy
Heath Skinner · Abrir el resumen
Oropharyngeal Squamous Cell Carcinoma · Fase 2 · NCT04852328
CUE-101
Washington University School of Medicine · Abrir el resumen
Head and Neck Squamous Cell Carcinoma · Fase 2 · NCT04375384 · Artículos
Cetuximab, Questionnaire administration, Quality of life assessment
Wake Forest University Health Sciences · Abrir el resumen
Head and Neck Cancer · Fase 2 · NCT07179315
cemiplimab+fianlimab, Cemiplimab
University of Chicago · Abrir el resumen
Gland · Fase 2 · NCT05884320 · Artículos
Sacituzumab Govitecan
M.D. Anderson Cancer Center · Abrir el resumen
Metastatic Oropharyngeal Carcinoma · Fase 2 · NCT05799144
DNA Vaccine, Human Papillomavirus Tumor Antigen Vaccine, Pembrolizumab, Computed Tomography (CT)
Michael K. Gibson · Abrir el resumen
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Fase 2 · NCT07178301
Computed Tomography, Nasopharyngeal Laryngoscopy, Positron Emission Tomography, Questionnaire Administration
Northwestern University · Abrir el resumen
Advanced Head and Neck Squamous Cell Carcinoma · Fase 2 · NCT07094685
Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ivonescimab
University of Michigan Rogel Cancer Center · Abrir el resumen
Nasopharyngeal Carcinoma · Fase 2 · NCT06592599
Toripalimab, Concurrent Chemoradiation and Adjuvant treatment following Chemoradiation
Stanford University · Abrir el resumen
Head and Neck Squamous Cell Carcinoma · Fase 2 · NCT05726370
Pembrolizumab, CISPLATIN, Carboplatin, Docetaxel
Dana-Farber Cancer Institute · Abrir el resumen
Squamous Cell Carcinoma of Head and Neck · Fase 2 · NCT05317000 · Artículos
Combination 5-azacytidine and nivolumab, Nivolumab
Barbara Burtness · Abrir el resumen